Inhibrx Biosciences Inc. (INBX)
NASDAQ: INBXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 93.36 0.00%
INBX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.37B
- EPS (TTM)
- -$8.88
- Dividend yield
- None
- 52-week range
- 28.16 – 155.29
- Day range
- 90.66 – 96.71
- Volume / Avg
- 223.50K / 296.25K
- Beta
- —
- Shares outstanding
- 14.72M
- Next earnings
- Nov 13, 2026
52-week range
INBX stock today
On Oct 7, INBX ended the session at $93.36, shedding $0.05 (0.05%), versus the S&P 500's 0.22% decline. Shares are 39.9% below their 52-week high of $155.29 and 231.5% above the 52-week low of $28.16, in the middle of the past year's range. Inhibrx Biosciences has posted a net loss over the last twelve months (EPS of -$8.88), so its P/E ratio is not meaningful.
Inhibrx Biosciences's next earnings report is expected on Nov 13, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Inhibrx Biosciences
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
Earnings
Earnings history- Next report
- Nov 13, 2026
Inhibrx Biosciences peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| COAGHemab Therapeutics Holdings Inc. | 28.70 | +1.16% | $1.34B | vs INBX |
| TSHATaysha Gene Therapies Inc. | 4.43 | +0.91% | $1.44B | vs INBX |
| MAZEMaze Therapeutics Inc. | 26.25 | -0.68% | $1.46B | vs INBX |
| REPLReplimune Group Inc. | 13.20 | -0.38% | $1.24B | vs INBX |
| IMCRImmunocore Holdings plc ADR | 29.41 | -0.47% | $1.51B | vs INBX |
| IMTXImmatics N.V. | 7.45 | -0.67% | $1.13B | vs INBX |
| VORVor Biopharma Inc. | 18.78 | +2.57% | $1.11B | vs INBX |
| MGTXMeiraGTx Holdings plc | 10.82 | +2.08% | $1.04B | vs INBX |
Indexes, lists and sector
Largest Health Care stocks
Inhibrx Biosciences stock FAQ
What is Inhibrx Biosciences's stock price today?
INBX last traded at $93.36 as of Oct 7, 4:00 PM EDT, down 0.05% on the day. Prices are delayed at least 15 minutes.
When is Inhibrx Biosciences's next earnings date?
Inhibrx Biosciences is expected to report earnings on Friday, November 13, 2026.
What is the INBX 52-week high?
The 52-week high for INBX is $155.29 and the 52-week low is $28.16. The stock is currently 39.9% below its high.